Eden Bio: Shareholder Xiamen Keying plans to reduce its holdings by no more than 1.22%

Eden Bio announced that Xiamen Keying, a shareholder holding 15,940,900 shares accounting for 4.08% of the shares, plans to reduce its holdings through block trading and centralized bidding within three months from the announcement, starting from the third trading day after the announcement, by a maximum of 4,775,100 shares, accounting for 1.22%. Reductions through consecutive 90 days of centralized bidding will not exceed 1%, and reductions through block trading will not exceed 2%. The price will be determined based on the market price at the time.